临床药师参与1例咯血伴血栓形成高风险肺癌患者的止血药物治疗

Clinical pharmacists participated in the hemostatic drug treatment of a lung cancer patient with hemoptysis and high risk of thrombosis

摘要:

目的 通过临床药师参与1例肺癌咯血伴静脉血栓形成高危风险患者的止血药物治疗方案制定，探讨临床药师参与此类患者个体化治疗的方法与思路。方法 临床药师利用药学专业知识参与临床会诊，评估患者病情，查阅相关资料，制定个体化止血药物治疗方案。结果 临床医师接受临床药师会诊建议，患者咯血明显减轻，未发生血栓，病情得到有效控制。结论 针对晚期肺癌咯血伴血栓形成高危风险患者的治疗，应当对其出血的具体机制进行分析，同时结合不同药物的特点合理选择药物。对该例患者的治疗提示临床药师可成为临床治疗团队中重要的一员，发挥专业作用，为患者提供有效的个体化治疗，提高临床用药的安全性与有效性。

Abstract:

Objective To explore the methods and ideas of clinical pharmacists participating in the individualized treatment of a lung cancer patient with hemoptysis and high risk of venous thrombosis through the participation of clinical pharmacists in the formulation of hemostatic drug treatment plan.Methods Clinical pharmacists participated in clinical consultation with their professional knowledge of pharmacy, assessed the patient's condition, consulted relevant data, and formulated individualized drug treatment for cancer patients.Results Clinicians accepted the advice of clinical pharmacists, and the hemoptysis of the patient was significantly reduced. No thrombosis occurred at last, and the condition of the patient was effectively controlled.Conclusion In the treatment of advanced lung cancer patients with hemoptysis and high risk of venous thrombosis, the specific mechanism of bleeding should be analyzed, and the drugs should be selected reasonably according to the characteristics of different drugs. Through the treatment of this patient, it is suggested that clinical pharmacists can be an important part of the clinical treatment team, and play a professional role in providing effective individualized treatment for patients and improving the safety and effectiveness of clinical medication.